Comparative Analysis of Human Brain RNA-seq Reveals the Combined Effects of Ferroptosis and Autophagy on Alzheimer's Disease in Multiple Brain Regions
- PMID: 39710824
- DOI: 10.1007/s12035-024-04642-2
Comparative Analysis of Human Brain RNA-seq Reveals the Combined Effects of Ferroptosis and Autophagy on Alzheimer's Disease in Multiple Brain Regions
Abstract
Ferroptosis and autophagy are closely associated with Alzheimer's disease (AD). Elevated ferric ion levels can induce oxidative stress and chronic inflammatory responses, resulting in brain tissue damage and further neurological cell damage. Autophagy in Alzheimer's has a dual role. On one hand, it protects neurons by removing β-amyloid and cellular damage products caused by oxidative stress and inflammation. On the other hand, abnormal autophagy is linked to neuronal apoptosis and neurodegeneration. However, the intricate interplay between ferroptosis and autophagy in AD remains insufficiently explored. This study focuses on the roles of ferroptosis and autophagy in AD and their interconnection through bioinformatics analysis, shedding light on the disease. Ferroptosis and autophagy significantly correlate with the development and course of AD. Using PPI network analysis and unsupervised consistency clustering analysis, we uncovered a complex network of interactions between ferroptosis and autophagy during disease progression, demonstrating a significant congruence in their modification patterns. Functional analyses further demonstrated that ferroptosis and autophagy together affect the immunological status and synaptic regulation in hippocampal regions in patients with AD, which significantly impacts the start and progression of the disease.
Keywords: Alzheimer’s; Autophagy; Ferroptosis; Immune; Inflammation; Synapse.
© 2024. The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer Nature.
Conflict of interest statement
Declarations. Ethics Approval: Not applicable. Consent to Participate: Not applicable. Consent for Publication: Not applicable. Competing Interests: The authors declare no competing interests.
References
-
- Ballard C, Gauthier S, Corbett A, Brayne C, Aarsland D, Jones E (2011) Alzheimer’s disease. Lancet 377(9770):1019–1031. https://doi.org/10.1016/S0140-6736(10)61349-9 - DOI - PubMed
-
- Scheltens P, De Strooper B, Kivipelto M, Holstege H, Chételat G, Teunissen CE, Cummings J, van der Flier WM (2021) Alzheimer’s disease. Lancet 397(10284):1577–1590. https://doi.org/10.1016/S0140-6736(20)32205-4 - DOI - PubMed - PMC
-
- Graff-Radford J, Yong KX, Apostolova LG, Bouwman FH, Carrillo M, Dickerson BC, Rabinovici GD, Schott JM et al (2021) New insights into atypical Alzheimer’s disease in the era of biomarkers. Lancet Neurol 20(3):222–234. https://doi.org/10.1016/S1474-4422(20)30440-3 - DOI - PubMed - PMC
-
- Dolgin E (2022) This is how an Alzheimer’s gene ravages the brain. Nature 611(7937):649. https://doi.org/10.1038/d41586-022-03724-2 - DOI - PubMed
-
- Wang D, Hui Y, Peng Y, Tang L, Jin J, He R, Li Y, Zhang S et al (2015) Overexpression of heme oxygenase 1 causes cognitive decline and affects pathways for tauopathy in mice. J Alzheimers Dis 43(2):519–534. https://doi.org/10.3233/JAD-140567 - DOI - PubMed
Publication types
MeSH terms
Grants and funding
- YJSCX2023-101HYD/Postgraduate Research & Practice Innovation Program of Harbin Medical University
- 2022YFE0118200/National Key R&D Program of China
- 2022M720521/China postdoctoral science foundation
- 2016M600261/China postdoctoral science foundation
- YQ2022H003/Natural Science Foundation of Heilongjiang Province of China (Outstanding Youth Foundation)
LinkOut - more resources
Full Text Sources
Medical